Julia Sanchez

16PUBLICATIONS
62CO-AUTHORS
Molecular targetsPredictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 21, 2025
Avelumab plus cetuximab in advanced cutaneous squamous cell carcinoma: a strategy to overcome resistance to PD-1 blockade.

Eve Maubec

|Aug 08, 2024
Clinical benefit from palbociclib, letrozole and goserelin combination therapy for sweat gland carcinoma with neuroendocrine differentiation (SCAND).

Sofia Tzoumpa, Claudia Bejar, Béatrice Villette

|Jun 12, 2024
Radiotherapy and prognostic factors in adnexal carcinomas: A retrospective study of 657 patients from the French CARADERM network.

Robin Zagala, Stephane Dalle, Marie Beylot-Barry

|Sep 09, 2023
Combined Nivolumab and Ipilimumab in Octogenarian and Nonagenarian Melanoma Patients.

Constance Reichert, Capucine Baldini, Sarah Mezghani

|Dec 22, 2022
Cost-Effectiveness Analysis of Sequential Treatment Strategies for Advanced Melanoma in Real Life in France.

Marguerite Kandel, Aurélie Bardet, Stéphane Dalle

|Nov 10, 2022
Non-V600E/K BRAF Mutations in Metastatic Melanoma: Molecular Description, Frequency, and Effectiveness of Targeted Therapy in a Large National Cohort.

Manon Girod, Stéphane Dalle, Laurent Mortier

Pageof 3

Frequent Collaborators

5 joint publications

Florence Brunet-Possenti

3 joint publications

Olivier Dereure

2 joint publications

Celeste Lebbe

2 joint publications

Marie Beylot-Barry